Clinical Trial Update: Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating oral tafenoquine plus standard of care versus placebo plus standard of care for babesiosis; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: 60 Degrees Pharmaceuticals LLC | Conditions: Babesiosis | Phase 2 | Status: RECRUITING